Cohen & Steers’s AbbVie ABBV Stock Holding History

Cohen & Steers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Hold	1,700	–	–	﹤0.01%	318
2026 Q1	$370K	Hold	1,700	–	–	﹤0.01%	316
2025 Q4	$388K	Hold	1,700	–	–	﹤0.01%	315
2025 Q3	$394K	Hold	1,700	–	–	﹤0.01%	313
2025 Q2	$316K	Hold	1,700	–	–	﹤0.01%	319
2025 Q1	$356K	Buy	+1,700	New	+$330K	﹤0.01%	303
2016 Q1	–	Sell	-3,000	Closed	-$178K	–	433
2015 Q4	$178K	Sell	3,000 -800	-21%	-$46.1K	﹤0.01%	412
2015 Q3	$207K	Sell	3,800 -700	-16%	-$45.6K	﹤0.01%	411
2015 Q2	$302K	Sell	4,500 -200	-4%	-$13.1K	﹤0.01%	425
2015 Q1	$275K	Buy	4,700 +1,400	+42%	+$84.6K	﹤0.01%	420
2014 Q4	$216K	Sell	3,300 -600	-15%	-$37.8K	﹤0.01%	423
2014 Q3	$225K	Sell	3,900 -1,200	-24%	-$66.6K	﹤0.01%	428
2014 Q2	$288K	Buy	5,100 +1,300	+34%	+$68.2K	﹤0.01%	403
2014 Q1	$195K	Buy	3,800 +700	+23%	+$35.4K	﹤0.01%	391
2013 Q4	$164K	Sell	3,100 -1,300	-30%	-$63.9K	﹤0.01%	397
2013 Q3	$197K	Sell	4,400 -400	-8%	-$17.7K	﹤0.01%	379
2013 Q2	$198K	Buy	+4,800	New	+$210K	﹤0.01%	365

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cohen & Steers's ABBV Position: Q2 2026 in Review

Cohen & Steers held its AbbVie (ABBV) position steady in Q2 2026 at 1,700 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Cohen & Steers first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cohen & Steers held 1,700 shares of AbbVie worth $428K as of Q2 2026.
Cohen & Steers left its AbbVie share count unchanged in Q2 2026.
AbbVie made up ﹤0.01% of Cohen & Steers's portfolio in Q2 2026, its #318 holding.
Cohen & Steers first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cohen & Steers's 13F filing for Q2 2026, filed 14 Aug 2026.